Viewing StudyNCT00126646



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126646
Status: COMPLETED
Last Update Posted: 2010-06-22
First Post: 2005-08-02

Brief Title: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia Prolymphocytic Leukemia or Non-Hodgkins Lymphoma
Sponsor: MedImmune LLC
Organization: MedImmune LLC

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Leukemia
Keywords:
Name View
prolymphocytic leukemia View
B-cell chronic lymphocytic leukemia View
refractory chronic lymphocytic leukemia View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
stage III grade 1 follicular lymphoma View
stage III grade 2 follicular lymphoma View
stage IV grade 1 follicular lymphoma View
stage IV grade 2 follicular lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View
recurrent marginal zone lymphoma View
splenic marginal zone lymphoma View
stage III marginal zone lymphoma View
stage IV marginal zone lymphoma View
recurrent mantle cell lymphoma View
stage III mantle cell lymphoma View
stage IV mantle cell lymphoma View
recurrent small lymphocytic lymphoma View
stage III small lymphocytic lymphoma View
stage IV small lymphocytic lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
stage III adult diffuse small cleaved cell lymphoma View
stage IV adult diffuse small cleaved cell lymphoma View
Waldenstrom macroglobulinemia View